GENOME ANNOUNCEMENT {#h0.0}
===================

Methicillin-resistant *Staphylococcus aureus* (MRSA) can cause serious community- and nosocomial-acquired infection. The use of vancomycin in the treatment of MRSA infection is challenged by the emergence of heteroresistant vancomycin-intermediate *S. aureus* (hVISA) and vancomycin-intermediate *S. aureus* (VISA). Several studies have reported the increasing frequency of hVISA/VISA-associated treatment failures in invasive infections ([@B1], [@B2]).

Here, we present the draft genome sequences of 11 hVISA strains isolated from bloodstream infections. All the isolates were found to have vancomycin MICs of 1 to 1.5 µg/ml. All these hVISA strains were confirmed with a population analysis profile-area under curve (PAP-AUC) method with the following PAP-AUC ratios: VB988, 1.03; VB9939, 0.92; VB16578, 0.96; VB20017, 1.0; VB44094, 0.97; VB44746, 1.33; VB46389, 1.03; VB35316, 0.96; BA43011, 1.28; *Staphylococcus aureus* strain 2016, 1.02; and VB1490, 1.0.

DNA isolation from pure cultures was performed using QIAamp DNA minikit (Qiagen, Germany). Whole-genome shotgun sequencing was performed using the Ion Torrent PGM system (Life Technologies, Inc.) with 400-bp chemistry. The raw data generated were assembled *de novo* using the assembler SPAdes version 5.0.0.0 embedded in Torrent suite server version 5.0.4. The genome sequence was annotated using PATRIC, the bacterial bioinformatics database and analysis resource (<http://www.patricbrc.org>) ([@B3]), and the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) (<http://www.ncbi.nlm.nih.gov/genome/annotation_prok/>) ([@B4]). Downstream analysis was performed using the Center for Genomic Epidemiology (CGE) server (<http://www.cbs.dtu.dk/services>) and PATRIC. The resistance gene profile was analyzed using ResFinder 2.1 from the CGE server (<https://cge.cbs.dtu.dk//services/ResFinder/>) ([@B5]). The CRISPR finder (<http://crispr.u-psud.fr/Server/>) was used to detect and identify clustered regularly interspaced short palindromic repeat (CRISPR) and spacer sequences in the genome. The sequence type was determined for all the isolates in the allele order of *arcc*, *aroe*, *glpf, gmk*, *pta*, *tpi,* and *yqil* by comparing the sequences with *S. aureus* database maintained at the MLST website ([http://saureus.mlst.net/](http://saureus.mlst.net)).

The annotated genome size of MRSA isolates ranged from \~2.7 to \~2.9 Mb, with coverages of 33× to 88× ([Table 1](#tab1){ref-type="table"}). The number of coding DNA sequences (CDSs) per genome ranged from 2,603 to 3,011. Genome annotation by PATRIC predicted a total of 41 to 60 tRNAs and five to 10 rRNAs in the sequenced isolates ([Table 1](#tab1){ref-type="table"}). All the isolates were found to harbor various toxin and antimicrobial resistance genes. Further, none of the isolates were found to have CRISPR regions.

###### 

Genome characteristics of hVISA isolates from bloodstream infection

  Isolate ID                            Accession no.                                                       Draft genome size (Mbp)   No. of CDSs   No. of contigs   No. of tRNAs   No. of rRNAs   Coverage (×)   Virulence genes[^a^](#ngtab1.1){ref-type="table-fn"}                                                                     Resistance genes                                                                                   ST/SCC*mec*/*spa* type[^b^](#ngtab1.2){ref-type="table-fn"}
  ------------------------------------- ------------------------------------------------------------------- ------------------------- ------------- ---------------- -------------- -------------- -------------- ------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------- -------------------------------------------------------------
  VB9882                                [MLQI00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQI00000000)   2.77                      2,692         132              60             10             79             *aur, scn, sak, seq, sen,seu, sei,sem, seo, seg, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV                      *aadD, acc(6′)-aph(2′′), mecA*, *blaZ*, *norA*                                                     2371/I/t6827
  VB9939                                [MLQK00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQK00000000)   2.83                      2,803         437              48             7              33             *aur, scn, seq, sem, seg, seo, sec3, sel, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV, *sen,seu, sea/sep*         *ant(6)-la, aph (3′)-III, acc(6′)-aph(2′′), spc, mecA*, *blaZ*, *norA, mph*(C)*, msr*(A), *dfrG*   772/V/t657
  VB16578                               [MLQD00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQD00000000)   2.79                      2,667         143              59             9              61             *aur, scn, seq, sen,seu, sei,sem, seo, seg,sec3, sel, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV                 *ant(6)-la, aph(3′)-III, acc(6′)-aph(2′′), spc, mecA*, *blaZ*, *norA, mph*(C)*, msr*(A), *dfrG*    772/V
  VB20017                               [MLQE00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQE00000000)   2.85                      2,916         420              41             5              34             *aur, scn, sak, seq, sen,seu, sei,sem, seo, seg, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV                      *aadD, acc(6′)-aph(2′′), mecA*, *blaZ*, *norA, ermC*                                               2371/V/ t6827
  VB44094                               [MLQH00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQH00000000)   2.77                      2,683         110              57             10             79             *aur, scn, sak, seq, sen,seu, sei,sem, seo, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV                           *acc(6′)-aph(2′′), mecA*, *blaZ*, *norA, ermC*                                                     22/IVc/t474
  VB44746                               [MLQF00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQF00000000)   2.84                      2,818         265              50             8              41             *splA*, *splE*, *aur*, *scn*, *sak*, *lukD*, *lukE*, *hlb*, *hlgB*, *hlgC*, *hlgA,eta*                                   *blaZ*, *norA, ermC*                                                                               1290/IVh/t131
  VB46389                               [MLQG00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQG00000000)   2.80                      2,700         235              50             7              42             *aur, scn, sea/sep, seg, seq, sen,seu, sei,sem, seo, seg,sec3, sel, hlb*, *hlgB*, *hlgC*, *hlgA*, *lukS-*PV, *lukF-*PV   *ant(6)-la, aph(3′)-III, acc(6′)-aph(2′′), mecA*, *blaZ, mph*(C)*, msrA*, *norA*, *dfrG*           772/V/t458
  VB35316                               [MLQC00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQC00000000)   2.77                      2,638         88               59             9              85             *splB*, *splA*, *splE, aur, scn, sak*, *lukD*, *lukE, seg, sen,seu, sei,sem, seo, hlb*, *hlgB*, *hlgC*, *hlgA*           *acc(6′)-aph(2′′), mecA*, *blaZ, norA*, *dfrG*                                                     72/III/V/t2473
  VB43011                               [MLQJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQJ00000000)   2.77                      2,604         67               59             8              76             *splB*, *splA*, *splE, aur, scn, sak, sea/sep, seb, seq, sek,seh*, *lukD*, *lukE, hlb*, *hlgB*, *hlgC*, *hlgA*           *ant(6)-la, aph(3′)-III*, *blaZ, mphC, msrA*, *norA*,                                              1/V/t127
  *Staphylococcus aureus* strain 2016   [MLQA00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQA00000000)   2.72                      2,603         85               60             9              88             *splA*, *splE*, *aur*, *scn*, *sak*, *lukD*, *lukE*, *hlb*, *hlgB*, *hlgC*, *hlgA*                                       *blaZ*, *norA*                                                                                     580/II/t4615
  VB1490                                [MLQB00000000](https://www.ncbi.nlm.nih.gov/nuccore/MLQB00000000)   2.97                      3,011         143              58             8              64             *splB, splA, splE, aur, scn, sak, seq, sek, lukD, lukE, hlb, hlgB, hlgC, hlgA*                                           *ant(6)-la, aph(3′)-III, acc(6′)-aph(2′′), spc, mecA, blaZ, norA, ermA, tet*(M)                    239/III/V/t037

PV, Panton-Valentine.

ST, sequence type; SCC*mec*, staphylococcal cassette chromosome *mec* element.

Infection with hVISA/VISA has been associated with high vancomycin MIC and poor clinical outcome. The most frequently mutated two-component system (TCS) determinants are *vraSR*, *graSR,* and *walKR,* and the *rpoB* gene ([@B6]). This chromosomal mutation leads to the upregulation of peptidoglycan biosynthesis and cell wall thickening and further prevents vancomycin from reaching its target ([@B7]). Multiple nonsynonymous mutations were seen in the *vraSR*, *graSR,* and *walKR* TCSs of all sequenced isolates. In addition, a mutation was seen in a teicoplanin resistance-associated (*tcaRAB*) operon. A mutation in the *rpoB* gene was not observed in any of the sequenced isolates.

Taken together, comparative genomic analysis of these sequenced isolates revealed preferential clustering of single nucleotide polymorphisms (SNPs) in hVISA candidate genes with high diversity across the loci of *vraSR*, *graSR*, *walKR*, and *tcaRAB*.

Accession number(s). {#s1}
--------------------

The draft genome sequences have been deposited in DDBJ/ENA/GenBank under the accession numbers as provided in [Table 1](#tab1){ref-type="table"}.
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